1.Defining Plasma cell disorders/Multiple Myeloma 2.Identification of different plasma cell disorders.
3.Diagnosis and workup for plasma cell disorders/Multiple Myeloma 4.Staging and prognosis
5.Treatment strategies
Copyright ©2010 American Society of Haematology. Copyright restrictions may apply.
Ghobrial, I. M. et al. ASH-SAP 2010;2010:581-604
Table 20-1 Diagnostic criteria for monoclonal gammopathies
Risk of progression of MGUS to myeloma or related disorder using a risk-stratification model that incorporates the FLC ratio and the size and type of the serum monoclonal protein.
Rajkumar S V et al. Blood 2005;106:812-817
©2005 by American Society of Hematology
*Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications Blood 2010, Bianchi et al
Copyright ©2010 American Society of Hematology. Copyright restrictions may apply.
Ghobrial, I. M. et al. ASH-SAP 2010;2010:581-604
Table 20-4 Staging systems for multiple myeloma: Durie-Salmon staging system and International Staging System (ISS)
Interaction between Plasma Cells and Bone Marrow in Multiple Myeloma.
Palumbo A, Anderson K. N Engl J Med 2011;364:1046-1060
QUESTIONS/COMMENTS